QSAM Biosciences Receives Notice of Allowance for European Patent and Expands Licensed IP Portfolio
10. Dezember 2020 09:00 ET
|
QSAM Biosciences Inc.
Palm Beach, FL, Dec. 10, 2020 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next generation nuclear medicines, including Cyclosam® Samarium-153-DOTMP, for the...